TNF and prostate cancer: Palbociclib treatment of PSCA-specific UniCAR T cells and CD3-PSCA bsAb-engaged T cells co-cultured with prostate cancer cells resulted in lower total concentrations of IFN-γ and TNF in the supernatants.